These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31893042)

  • 1. Molecular surveillance of carbapenemase-producing
    Schäfer E; Malecki M; Tellez-Castillo CJ; Pfennigwerth N; Marlinghaus L; Higgins PG; Mattner F; Wendel AF
    Antimicrob Resist Infect Control; 2019; 8():208. PubMed ID: 31893042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia.
    Vanegas JM; Cienfuegos AV; Ocampo AM; López L; del Corral H; Roncancio G; Sierra P; Echeverri-Toro L; Ospina S; Maldonado N; Robledo C; Restrepo A; Jiménez JN
    J Clin Microbiol; 2014 Nov; 52(11):3978-86. PubMed ID: 25210071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
    J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of isolates of carbapenemase-producing Pseudomonas aeruginosa from seven Colombian provinces].
    Saavedra SY; Duarte C; González MN; Realpe ME
    Biomedica; 2014 Apr; 34 Suppl 1():217-23. PubMed ID: 24968053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla
    PÉrez-VÁzquez M; Sola-Campoy PJ; Zurita ÁM; Ávila A; GÓmez-Bertomeu F; SolÍs S; LÓpez-Urrutia L; GÓnzalez-BarberÁ EM; Cercenado E; Bautista V; Lara N; Aracil B; Oliver A; Campos J; Oteo-Iglesias J;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
    Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey.
    Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME
    Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.
    Hong JS; Yoon EJ; Lee H; Jeong SH; Lee K
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7216-7223. PubMed ID: 27671068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima.
    Kouda S; Ohara M; Onodera M; Fujiue Y; Sasaki M; Kohara T; Kashiyama S; Hayashida S; Harino T; Tsuji T; Itaha H; Gotoh N; Matsubara A; Usui T; Sugai M
    J Antimicrob Chemother; 2009 Jul; 64(1):46-51. PubMed ID: 19398456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National surveillance pilot study unveils a multicenter, clonal outbreak of VIM-2-producing Pseudomonas aeruginosa ST111 in the Netherlands between 2015 and 2017.
    Pirzadian J; Persoon MC; Severin JA; Klaassen CHW; de Greeff SC; Mennen MG; Schoffelen AF; Wielders CCH; Witteveen S; van Santen-Verheuvel M; Schouls LM; Vos MC;
    Sci Rep; 2021 Oct; 11(1):21015. PubMed ID: 34697344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.
    Crespo MP; Woodford N; Sinclair A; Kaufmann ME; Turton J; Glover J; Velez JD; Castañeda CR; Recalde M; Livermore DM
    J Clin Microbiol; 2004 Nov; 42(11):5094-101. PubMed ID: 15528701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.
    Mikucionyte G; Zamorano L; Vitkauskiene A; López-Causapé C; Juan C; Mulet X; Oliver A
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):195-200. PubMed ID: 26638216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of several phenotypic methods for the detection of carbapenemase-producing Pseudomonas aeruginosa.
    Heinrichs A; Huang TD; Berhin C; Bogaerts P; Glupczynski Y
    Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1467-74. PubMed ID: 25896858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.